119 related articles for article (PubMed ID: 34959645)
21. Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design.
Ling G; Gao J; Zhang S; Xie Z; Wei L; Yu H; Wang Y
PLoS One; 2014; 9(3):e93216. PubMed ID: 24675879
[TBL] [Abstract][Full Text] [Related]
22. Structure, dynamics and mapping of membrane-binding residues of micelle-bound antimicrobial peptides by natural abundance (13)C NMR spectroscopy.
Wang G
Biochim Biophys Acta; 2010 Feb; 1798(2):114-21. PubMed ID: 19682427
[TBL] [Abstract][Full Text] [Related]
23. Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.
Majewski K; Kozłowska E; Żelechowska P; Brzezińska-Błaszczyk E
Cent Eur J Immunol; 2018; 43(4):453-457. PubMed ID: 30799994
[TBL] [Abstract][Full Text] [Related]
24. Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics.
Gupta K; Singh S; van Hoek ML
Antibiotics (Basel); 2015 Aug; 4(3):358-78. PubMed ID: 27025629
[TBL] [Abstract][Full Text] [Related]
25. The Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against
Luo Y; McLean DT; Linden GJ; McAuley DF; McMullan R; Lundy FT
Front Microbiol; 2017; 8():544. PubMed ID: 28408902
[TBL] [Abstract][Full Text] [Related]
26. Antibiofilm Activity of LL-37 Peptide and D-Amino Acids Associated with Antibiotics Used in Regenerative Endodontics on an Ex Vivo Multispecies Biofilm Model.
Pereira ACC; Aguiar APS; Araujo LMP; Dantas LO; Mayer MPA; Karygianni L; Thurnheer T; Pinheiro ET
Life (Basel); 2022 Oct; 12(11):. PubMed ID: 36362840
[TBL] [Abstract][Full Text] [Related]
27. Determination of solution structure and lipid micelle location of an engineered membrane peptide by using one NMR experiment and one sample.
Wang G
Biochim Biophys Acta; 2007 Dec; 1768(12):3271-81. PubMed ID: 17905196
[TBL] [Abstract][Full Text] [Related]
28.
Siano A; Humpola MV; de Oliveira E; Albericio F; Simonetta AC; Lajmanovich R; Tonarelli GG
Molecules; 2018 Nov; 23(11):. PubMed ID: 30423858
[TBL] [Abstract][Full Text] [Related]
29. Transforming Cross-Linked Cyclic Dimers of KR-12 into Stable and Potent Antimicrobial Drug Leads.
Muhammad T; Strömstedt AA; Gunasekera S; Göransson U
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831040
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT.
Esposito TVF; Rodríguez-Rodríguez C; Blackadar C; Kłodzińska S; Mørck Nielsen H; Saatchi K; Häfeli UO
Eur J Pharm Biopharm; 2024 Jul; ():114398. PubMed ID: 38972467
[TBL] [Abstract][Full Text] [Related]
31. Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants.
Mirzaee M; Holásková E; Mičúchová A; Kopečný DJ; Osmani Z; Frébort I
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438948
[TBL] [Abstract][Full Text] [Related]
32. Regulation of LL-37 in Bone and Periodontium Regeneration.
Chinipardaz Z; Zhong JM; Yang S
Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294968
[TBL] [Abstract][Full Text] [Related]
33. Cathelicidin LL-37 in Health and Diseases of the Oral Cavity.
Tokajuk J; Deptuła P; Piktel E; Daniluk T; Chmielewska S; Wollny T; Wolak P; Fiedoruk K; Bucki R
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625823
[TBL] [Abstract][Full Text] [Related]
34. Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.
Girnita A; Zheng H; Grönberg A; Girnita L; Ståhle M
Oncogene; 2023 Feb; 42(8):626. PubMed ID: 36494433
[No Abstract] [Full Text] [Related]
35. Correction to: Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression.
Chen X; Deng S; Wang W; Castiglione S; Duan Z; Luo L; Cianci F; Zhang X; Xu J; Li H; Zhao J; Kamau PM; Zhang Z; Mwangi J; Li J; Shu Y; Hu X; Mazzanti M; Lai R
Mol Psychiatry; 2024 Jan; 29(1):54-55. PubMed ID: 37015981
[No Abstract] [Full Text] [Related]
36. Reversible female contraceptives: historical, current, and future perspectives†.
Barton BE; Erickson JA; Allred SI; Jeffries JM; Stephens KK; Hunter MI; Woodall KA; Winuthayanon W
Biol Reprod; 2024 Jan; 110(1):14-32. PubMed ID: 37941453
[TBL] [Abstract][Full Text] [Related]
37. Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism.
Wu Q; Mishra B; Wang G
Pept Sci (Hoboken); 2022 Sep; 114(5):. PubMed ID: 36249542
[No Abstract] [Full Text] [Related]
38. The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.
Ramírez-Ledesma MG; Rodríguez MC; Alva-Murillo N; Avila EE
Parasitol Res; 2022 Dec; 121(12):3503-3512. PubMed ID: 36171407
[TBL] [Abstract][Full Text] [Related]
39. Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy.
Lu F; Zhu Y; Zhang G; Liu Z
Front Pharmacol; 2022; 13():944147. PubMed ID: 36081952
[TBL] [Abstract][Full Text] [Related]
40. 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae.
Lee SG; Kiattiburut W; Khongkha T; Schinkel SCB; Lunn Y; Decker AP; Mohammadi A; Vera-Cruz A; Misra A; Angel JB; Anderson DJ; Baker M; Kaul R; Wang G; Tanphaichitr N
Hum Reprod; 2022 Oct; 37(11):2503-2517. PubMed ID: 36053257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
